A carregar...
Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)
The FDA guidance for industry in the premarketing clinical evaluation of drug-induced liver injury (DILI) is the most specific regulatory guidance currently available and has been useful in setting standards for the great majority of clinical indications involving subjects with a low risk of liver d...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4212149/ https://ncbi.nlm.nih.gov/pubmed/25352328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-014-0186-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|